Skip to main content

Table 5 predictors of length of hospital stay among T2D patients at government hospitals of Harari regional state of Ethiopia (2013–2017) (n = 135)

From: Magnitude and predictors of hospital admission, readmission, and length of stay among patients with type 2 diabetes at public hospitals of Eastern Ethiopia: a retrospective cohort study

Length of hospital stay

Categories

Median (IQR) LOS (wk.)

Adjusted RR (95%CI)

Sex

Male

0.75 (1.17)

1

Female

1.09 (1.79)

1.12 (1.04, 2.52) *

Duration of disease (year)

 

0.92 (1.51)

0.63 (0.49, 1.81)

Smoking

No

0.95 (1.54)

1

Yes

0.55 (1.02)

0.73 (0.46, 1.16)

Blood glucose level

Per 10 dl/ml

0.92 (1.51)

1.04 (1.02, 1.07) **

Recent BMI

< 25 kg/m2

0.87 (1.42)

1

25–29.9 kg/m2

1.08 (1.77)

1.46 (0.057, 3.67)

> 30 kg/m2

1.23 (1.75)

2.15 (0.54, 8.55)

Insulin administered

No

0.72 (1.34)

1

Yes

1.88 (1.89)

3.41 (1.30, 8.98) *

Treatment

Metformin only

1.2 (1.4)

1

Combinationa

0.9 (1.32)

0.35 (0.14, 0.85) *

Subject: Variance

  

2.03 (1.64, 2.52) *

  1. IQR Inter quartile range, LOS length of hospital, wk weeks, mg/dl milligram per deciliter, RR relative risk, CI confidence interval, kg/m2 kilograms per meter square, *; p-value< 0.05 **; p-value< 0.001
  2. a: taking both metformin and glibenclamide